1987
DOI: 10.1007/978-3-642-83170-6_46
|View full text |Cite
|
Sign up to set email alerts
|

Vergleichende Untersuchung des prostataspezifischen Antigens und der prostataspezifischen sauren Phosphatase in der Diagnostik und Verlaufskontrolle des Prostatakarzinoms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
0
0

Year Published

1992
1992
1992
1992

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 4 publications
2
0
0
Order By: Relevance
“…In stage pT2pNoM0, only 6 of 66 patients (9.1 %) showed ele vated PAP serum levels in comparison to 47 of the 66 patients (71.2%) in whom elevated PSA levels were de tected. Similar results were reported previously from our institution [20,21]. Thus, PAP obviously is of no value in detecting early prostatic cancer.…”
Section: Discussionsupporting
confidence: 81%
“…In stage pT2pNoM0, only 6 of 66 patients (9.1 %) showed ele vated PAP serum levels in comparison to 47 of the 66 patients (71.2%) in whom elevated PSA levels were de tected. Similar results were reported previously from our institution [20,21]. Thus, PAP obviously is of no value in detecting early prostatic cancer.…”
Section: Discussionsupporting
confidence: 81%
“…In stage pT2pN0M0, only 6 of 66 patients (9.1 %) showed ele vated PAP serum levels in comparison to 47 of the 66 patients (71.2%) in whom elevated PSA levels were de tected. Similar results were reported previously by our institution [20,21]. thus, PAP obviously is of no value in detecting early prostatic cancer.…”
Section: Wirth/frohmiillersupporting
confidence: 81%